NCT06587906 Postoperative Complications Following Skull Base Tumor Resection
| NCT ID | NCT06587906 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Beijing Tiantan Hospital |
| Condition | Skull Base Tumor |
| Study Type | OBSERVATIONAL |
| Enrollment | 122 participants |
| Start Date | 2024-09-10 |
| Primary Completion | 2027-09-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 122 participants in total. It began in 2024-09-10 with a primary completion date of 2027-09-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The skull base tumor is located in the deep intracranial layer and is closely related to the brain stem and intracranial nerves. The incidence of postoperative complications after skull base tumor resection is high. Therefore, the perioperative management of skull base tumor resection is challenging.
Eligibility Criteria
Inclusion Criteria: * Age 18 and above * American Society of Anesthesiologists physical status I to III * Undergoing elective resection of skull base tumors * Obtaining written informed consent Exclusion Criteria: * Heart failure, myocarditis, pericarditis, and cardiomyopathy * Myocardial ischemia less than 6 months old * Severe arrhythmia * Severe bradycardia (heart rate below 50 beats per minute) * Unable to complete preoperative cardiac assessment * Severe liver dysfunction (Child Pugh C-grade) * Severe lung diseases
Contact & Investigator
Yuming Peng
STUDY CHAIR
Beijing Tiantan Hospital
Frequently Asked Questions
Who can join the NCT06587906 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Skull Base Tumor. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06587906 currently recruiting?
Yes, NCT06587906 is actively recruiting participants. Contact the research team at florapym766@163.com for enrollment information.
Where is the NCT06587906 trial being conducted?
This trial is being conducted at Beijing, China.
Who is sponsoring the NCT06587906 clinical trial?
NCT06587906 is sponsored by Beijing Tiantan Hospital. The principal investigator is Yuming Peng at Beijing Tiantan Hospital. The trial plans to enroll 122 participants.